Myasthenia gravis in women.

Myasthenia Gravis (MG) often affects young women, in whom reproductive issues are of importance, including the possibility of MG exacerbation during pregnancy, potential obstetric risks in pregnancy and treatment-related risks to the fetus. Apart from pregnancy, hormonal changes throughout a woman's lifespan may also affect MG symptoms. In this chapter, we discuss the role of sex hormones in MG and the disease burden in women. We also review the effects of pregnancy on MG, the evidence regarding pregnancy outcomes and current recommendations regarding MG treatments during pregnancy.